Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil TCI for early extubation after cardiac surgery
NCT02033629Phase 3Completed
- Sponsor
- Imam Abdulrahman Bin Faisal University
- Start
- May 2014
- Primary completion
- May 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of remifentanil in cardiac surgery, sponsored by Imam Abdulrahman Bin Faisal University. Started May 2014; status: completed.
02
Drugs
remifentanil
03
Conditions
cardiac surgery
Beyond the preview
Go deeper on NCT02033629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02033629.